tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Schmidt, 145 are a BUY (78.38%), 40 are a HOLD (21.62%).
Analyst Michael Schmidt, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 54.24% that have a potential upside of 41.3% achieved within 272 days.
Michael Schmidt’s has documented 387 price targets and ratings displayed on 46 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KYMR, Kymera Therapeutics at 12-May-2025.
Analyst best performing recommendations are on IONS (IONIS PHARMACEUTICALS).
The best stock recommendation documented was for IONS (IONIS PHARMACEUTICALS) at 7/14/2016. The price target of $26 was fulfilled within 1 day with a profit of $1.48 (6.04%) receiving and performance score of 60.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$4
2 years 11 months 4 days ago
(14-Jun-2022)
0/11 (0%)
$2.53 (172.11%)
Hold
$4.75
$4.66 (5177.78%)
$5.75
3 years 6 months 15 days ago
(03-Nov-2021)
10/12 (83.33%)
$0.06 (1.28%)
65
Sell
4 years 6 months 12 days ago
(06-Nov-2020)
3/5 (60%)
$5.73 (134.19%)
42
Buy
$16
$15.91 (17677.78%)
$17
4 years 9 months 11 days ago
(07-Aug-2020)
5/12 (41.67%)
$10.58 (195.20%)
77
Sell
$4
$3.91 (4344.44%)
$3
5 years 12 days ago
(06-May-2020)
3/5 (60%)
$-4.07 (-50.43%)
191
Which stock is Michael Schmidt is most bullish on?
Which stock is Michael Schmidt is most reserved on?
What Year was the first public recommendation made by Michael Schmidt?
